287 related articles for article (PubMed ID: 31169496)
1. A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma.
Guo W; Zhu L; Zhu R; Chen Q; Wang Q; Chen JQ
Elife; 2019 Jun; 8():. PubMed ID: 31169496
[TBL] [Abstract][Full Text] [Related]
2. The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma.
Song LB; Luan JC; Zhang QJ; Chen L; Wang HY; Cao XC; Song NH; Lu Y
J Immunol Res; 2021; 2021():6686284. PubMed ID: 33688507
[TBL] [Abstract][Full Text] [Related]
3. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
4. Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients.
Sigalotti L; Fratta E; Bidoli E; Covre A; Parisi G; Colizzi F; Coral S; Massarut S; Kirkwood JM; Maio M
J Transl Med; 2011 May; 9():78. PubMed ID: 21615918
[TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of Ferroptosis-Related DNA Methylation Signature for Predicting the Prognosis and Guiding the Treatment in Cutaneous Melanoma.
Guo W; Wang X; Wang Y; Zhu S; Zhu R; Zhu L
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555319
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of the B Cell-Associated Fc Receptor-like Molecule-Based Prognostic Signature in Skin Cutaneous Melanoma.
Liu Y; Chen Y; Hu X; Meng J; Li X
Biomed Res Int; 2020; 2020():8509805. PubMed ID: 32908921
[TBL] [Abstract][Full Text] [Related]
7. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
[TBL] [Abstract][Full Text] [Related]
8. Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma.
Fröhlich A; Sirokay J; Fietz S; Vogt TJ; Dietrich J; Zarbl R; Florin M; Kuster P; Saavedra G; Valladolid SR; Hoffmann F; Flatz L; Ring SS; Golletz C; Pietsch T; Strieth S; Brossart P; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D
EBioMedicine; 2020 Sep; 59():102962. PubMed ID: 32861198
[TBL] [Abstract][Full Text] [Related]
9. Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma.
Qu Y; Zhang S; Zhang Y; Feng X; Wang F
Virchows Arch; 2021 May; 478(5):943-959. PubMed ID: 33179141
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma.
Fröhlich A; Loick S; Bawden EG; Fietz S; Dietrich J; Diekmann E; Saavedra G; Fröhlich H; Niebel D; Sirokay J; Zarbl R; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D
EBioMedicine; 2020 Feb; 52():102647. PubMed ID: 32028068
[TBL] [Abstract][Full Text] [Related]
11. A six-long non-coding RNA signature predicts prognosis in melanoma patients.
Yang S; Xu J; Zeng X
Int J Oncol; 2018 Apr; 52(4):1178-1188. PubMed ID: 29436619
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma.
Thakur R; Laye JP; Lauss M; Diaz JMS; O'Shea SJ; Poźniak J; Filia A; Harland M; Gascoyne J; Randerson-Moor JA; Chan M; Mell T; Jönsson G; Bishop DT; Newton-Bishop J; Barrett JH; Nsengimana J
Clin Cancer Res; 2019 Dec; 25(24):7424-7435. PubMed ID: 31515461
[TBL] [Abstract][Full Text] [Related]
13. A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.
Hanniford D; Zhong J; Koetz L; Gaziel-Sovran A; Lackaye DJ; Shang S; Pavlick A; Shapiro R; Berman R; Darvishian F; Shao Y; Osman I; Hernando E
Clin Cancer Res; 2015 Nov; 21(21):4903-12. PubMed ID: 26089374
[TBL] [Abstract][Full Text] [Related]
14. Construction of Circadian Clock Signature for Tumor Microenvironment in Predicting Survival for Cutaneous Melanoma.
Zeng N; Xia Q; Li Y; Ma L; Cheng Y; Chen Y; Lu Q; Lu Z; Wu D; Luo D
Curr Pharm Des; 2022; 28(28):2349-2361. PubMed ID: 35927923
[TBL] [Abstract][Full Text] [Related]
15. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
de Unamuno Bustos B; Murria Estal R; Pérez Simó G; Simarro Farinos J; Pujol Marco C; Navarro Mira M; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
Br J Dermatol; 2018 Aug; 179(2):394-404. PubMed ID: 29278418
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma.
Wouters J; Vizoso M; Martinez-Cardus A; Carmona FJ; Govaere O; Laguna T; Joseph J; Dynoodt P; Aura C; Foth M; Cloots R; van den Hurk K; Balint B; Murphy IG; McDermott EW; Sheahan K; Jirström K; Nodin B; Mallya-Udupi G; van den Oord JJ; Gallagher WM; Esteller M
BMC Med; 2017 Jun; 15(1):101. PubMed ID: 28578692
[TBL] [Abstract][Full Text] [Related]
17. Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma.
Gerami P; Cook RW; Wilkinson J; Russell MC; Dhillon N; Amaria RN; Gonzalez R; Lyle S; Johnson CE; Oelschlager KM; Jackson GL; Greisinger AJ; Maetzold D; Delman KA; Lawson DH; Stone JF
Clin Cancer Res; 2015 Jan; 21(1):175-83. PubMed ID: 25564571
[TBL] [Abstract][Full Text] [Related]
18. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
Liu X; Wang J
Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111
[TBL] [Abstract][Full Text] [Related]
19. A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma.
Guo W; Zhu L; Yu M; Zhu R; Chen Q; Wang Q
Clin Epigenetics; 2018 Nov; 10(1):142. PubMed ID: 30446011
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma.
Jiang Y; Zhang C; Zhang J; Han D; Shi X
Int Immunopharmacol; 2021 Dec; 101(Pt A):108344. PubMed ID: 34763233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
